Patents by Inventor Muddasani Pulla Reddy

Muddasani Pulla Reddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the preparation of Sugammadex sodium and its novel polymorphic form
    Patent number: 11845811
    Abstract: The present invention provides an improved process for the preparation of Sugammadex sodium of formula (I) having more than 98.5% purity along with less than 1.0% monohydroxy Sugammadex sodium and less than 0.15% any other known or unknown impurities by HPLC.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: December 19, 2023
    Assignee: NATCO PHARMA LIMITED
    Inventors: Vanga Prabhakar, Baddula Saidulu, Kotte Rajashekar, Peddi Rajasekhara Reddy, Vuppalapati Naga Vasanta Srinivasu, Konduri Srinivasa Krishna Murthy, Budideti Shankar Reddy, Muddasani Pulla Reddy, Nannapaneni Venkaiah Chowdary
  • Process for the preparation of Cabozantinib and its pharmaceutically acceptable salts thereof
    Patent number: 11498902
    Abstract: The present invention relates to an improved process for the preparation of N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N?-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide compound of formula-1 which is represented by the following structural formula:
    Type: Grant
    Filed: June 4, 2019
    Date of Patent: November 15, 2022
    Assignee: NATCO PHARMA LIMITED
    Inventors: Kompella Amala, Gampa Venugopala Krishna, Annadasu Ankamanayudu, Ganganamoni Srinivasulu, Konakanchi Durga Prasad, Muddasani Pulla Reddy, Nannapaneni Venkaiah Chowdary
  • AN IMPROVED PROCESS FOR THE PREPARATION OF SUGAMMADEX SODIUM AND ITS NOVEL POLYMORPHIC FORM
    Publication number: 20210355248
    Abstract: The present invention provides an improved process for the preparation of Sugammadex sodium of formula (I) having more than 98.5% purity along with less than 1.0% monohydroxy Sugammadex sodium and less than 0.15% any other known or unknown impurities by HPLC.
    Type: Application
    Filed: September 18, 2019
    Publication date: November 18, 2021
    Inventors: Vanga PRABHAKAR, Baddula SAIDULU, Kotte RAJASHEKAR, Peddi RAJASEKHARA REDDY, Vuppalapati NAGA VASANTA SRINIVASU, Konduri SRINIVASA KRISHNA MURTHY, Budideti SHANKAR REDDY, Muddasani PULLA REDDY, Nannapaneni VENKAIAH CHOWDARY
  • AN IMPROVED PROCESS FOR THE PREPARATION OF CABOZANTINIB AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
    Publication number: 20210188776
    Abstract: The present invention relates to an improved process for the preparation of N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N?-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide compound of formula-1 which is represented by the following structural formula:
    Type: Application
    Filed: June 4, 2019
    Publication date: June 24, 2021
    Inventors: Kompella AMALA, Gampa VENUGOPALA KRISHNA, Annadasu ANKAMANAYUDU, Ganganamoni SRINIVASULU, Konakanchi DURGA PRASAD, Muddasani PULLA REDDY, Nannapaneni VENKAIAH CHOWDARY
  • Pyrazolo [3,4-D] pyrimidine derivatives as anti-cancer agents
    Patent number: 8349847
    Abstract: The invention relates to substituted pyrazolo[3,4-d]pyrimidine derivatives of the Formula-(I), or pharmaceutically-acceptable salts thereof, which possess anti-proliferative activity such as anti-cancer activity and are accordingly useful in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of substituted pyrazolo[3,4-d]pyrimidine derivatives, to pharmaceutical compositions containing the compound and to its use in the manufacture of medicaments for the production of an anti-proliferative effect in a warm-blooded animal such as man.
    Type: Grant
    Filed: January 12, 2009
    Date of Patent: January 8, 2013
    Inventors: Durga Prasad Konakanchi, Subba Rao Pula, Lakshmi Ananthaneni, Ramakrishna Pilli, Muddasani Pulla Reddy, Bhujanga rao Adibhatla Satya, Nannapaneni Venkaiah Chowdary
  • 4-(tetrazol-5-yl)-quinazoline derivatives as anti-cancer agent
    Patent number: 8080558
    Abstract: The invention relates to substituted 4-(tetrazol-5-yl)-quinazoline derivatives of the formula-I, or pharmaceutically-acceptable salts thereof, which possess anti-proliferative activity such as anti-cancer activity and are accordingly useful in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of substituted 4-(tetrazol-5-yl)-quinazoline derivatives, to pharmaceutical compositions containing the compound and to its use in the manufacture of medicaments for the production of an anti-proliferative effect in a warm-blooded animal such as man.
    Type: Grant
    Filed: October 28, 2008
    Date of Patent: December 20, 2011
    Assignee: Natco Pharma Limited
    Inventors: Durga Prasad Konakanchi, Subba Rao Pula, Lakshmi Ananthaneni, Muddasani Pulla Reddy, Bhujanga Rao Adibhatla Kali Satya, Nannapaneni Venkaiah Chowdary
  • NOVEL PYRAZOLO [3, 4 -D] PYRIMIDINE DERIVATIVES AS ANTI-CANCER AGENTS
    Publication number: 20100298351
    Abstract: The invention relates to substituted pyrazolo[3,4-d]pyrimidine derivatives of the Formula-(I), or pharmaceutically-acceptable salts thereof, which possess anti-proliferative activity such as anti-cancer activity and are accordingly useful in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of substituted pyrazolo[3,4-d]pyrimidine derivatives, to pharmaceutical compositions containing the compound and to its use in the manufacture of medicaments for the production of an anti-proliferative effect in a warm-blooded animal such as man.
    Type: Application
    Filed: January 12, 2009
    Publication date: November 25, 2010
    Applicant: Natco Pharma Limited
    Inventors: Durga Prasad Konakanchi, Subba Rao Pula, Lakshmi Ananthaneni, Ramakrishna Pilli, Muddasani Pulla Reddy, Bhujanga Rao Adibhatla Satya, Nannapaneni Venkaiah Chowdary
  • NOVEL 4-(TETRAZOL-5-YL)-QUINAZOLINE DERIVATIVES AS ANTI CANCER AGENT
    Publication number: 20100261740
    Abstract: The invention relates to substituted 4-(tetrazol-5-yl)-quinazoline derivatives of the formula-I, or pharmaceutically-acceptable salts thereof, which possess anti-proliferative activity such as anti-cancer activity and are accordingly useful in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of substituted 4-(tetrazol-5-yl)-quinazoline derivatives, to pharmaceutical compositions containing the compound and to its use in the manufacture of medicaments for the production of an anti-proliferative effect in a warm-blooded animal such as man.
    Type: Application
    Filed: October 28, 2008
    Publication date: October 14, 2010
    Applicant: Natco Pharma Limited
    Inventors: Durga Prasad Konkanchi, Subba Rao Pula, Lakshmi Anathaneni, Muddasani Pulla Reddy, Bhujanga Rao Adibhatla Kali Satya, Nannapaneni Venkaiah Chowdary